As of 2024-12-12, the Fair Value of Sprint Bioscience AB (SPRINT.ST) is -1.37 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.67 SEK, the upside of Sprint Bioscience AB is -181.75%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -21.54 | -42.79 | -25.08 | -60.17 | -0.44 | -30.00 |
| YoY growth | 32.47% | -98.70% | 41.38% | -139.88% | 99.27% | -13.09% |
| Market Cap (mil) | 116.88 |
| P/E | |
| Forward P/E |
| EPS | -0.27 |
| Avg earnings growth rate | -13.09% |
| TTM earnings | -19.11 |